ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MO Altria Group Inc

43.37
-0.61 (-1.39%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Altria Group Inc NYSE:MO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.61 -1.39% 43.37 44.12 43.37 44.00 11,228,969 01:00:00

U.S. Tobacco Companies File Suit Against FDA Over Label Regulations

15/04/2015 10:03am

Dow Jones News


Altria (NYSE:MO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Altria Charts.
By Tripp Mickle 

The biggest U.S. tobacco companies filed a lawsuit against the U.S. Food and Drug Administration Tuesday, challenging its effort to assert authority over labels on tobacco products.

The suit follows a document the FDA issued in March that tobacco subsidiaries of Altria Group Inc., Reynolds-American Inc. and Lorillard Inc. argue violates the Tobacco Control Act by requiring them to submit labels for approval.

The makers of Marlboro, Camel and Newport cigarettes argue the Tobacco Control Act, which gave the FDA authority to regulate tobacco, limited the agency's authority over labels to tobacco products that make a "modified risk" claim. Otherwise, they should be able to change the color or look of their packaging as they wish.

"We disagree that FDA's new requirements that manufacturers must obtain agency authorization before changing certain product labels when the actual physical tobacco product remains exactly the same," said Brian May, an Altria spokesman. "We're asking the court to resolve these issues so that we and other manufacturers know how to proceed."

The FDA said it doesn't comment on litigation.

Write to Tripp Mickle at tripp.mickle@wsj.com

Access Investor Kit for Altria Group, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US02209S1033

Access Investor Kit for Lorillard, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US5441471019

Access Investor Kit for Reynolds American, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US7617131062

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Altria Chart

1 Year Altria Chart

1 Month Altria Chart

1 Month Altria Chart

Your Recent History

Delayed Upgrade Clock